Caucig P, Lescau S, Knop J, Maurer M, von Stebut E Interleukin-2 immediate type hypersensitivity? [JOURNAL ARTICLE] J Dtsch Dermatol Ges 2008 May 21.
Two patients with metastatic malignant melanoma developed immediate type hypersensitivity-like symptoms while being treated with recombinant interleukin-(IL-)2 immunotherapy. Both patients showed positive skin prick tests to IL-2, enhanced basophil degranulation in vitro and responded to anti-histamines, but laboratory investigations suggested an IgE-independent, pseudoallergic mast cell degranulation against IL-2.
More from this journal |